Chester Zygmont

Chester Zygmont

Director of Finance/CFO presso REVELATION BIOSCIENCES, INC.

Patrimonio netto: 1 811 $ in data 31/03/2024

44 anni
Health Technology
Consumer Services
Finance

Profilo

Chester S.
Zygmont
is the founder of Ooxesis Biotech LLC.
He currently holds the position of Chief Financial Officer & Director at Revelation Therapeutics LLC and Secretary, Chief Financial & Accounting Officer at Revelation Biosciences, Inc. Previously, he worked as a Senior Director-Finance at La Jolla Pharmaceutical Co. from 2012 to 2016 and as a Managing Director at Z3 Capital LLC from 2009 to 2012.
He also held the position of Vice President at Symmetry Advisors.
Mr. Zygmont completed his undergraduate degree at Eastern University and his graduate degree at Zicklin School of Business.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
18/03/2024 661 ( 0.04% ) 1 811 $ 31/03/2024

Posizioni attive di Chester Zygmont

SocietàPosizioneInizio
REVELATION BIOSCIENCES, INC. Director of Finance/CFO 01/05/2020
Director of Finance/CFO -
Tutte le posizioni attive di Chester Zygmont

Precedenti posizioni note di Chester Zygmont

SocietàPosizioneFine
Ooxesis Biotech LLC Founder 30/10/2021
LA JOLLA PHARMACEUTICAL COMPANY Director of Finance/CFO 01/01/2016
Corporate Officer/Principal 01/06/2012
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Chester Zygmont

Formazione di Chester Zygmont

Eastern University Undergraduate Degree
Zicklin School of Business Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Chester Zygmont

Relazioni

16

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
REVELATION BIOSCIENCES, INC.

Health Technology

Aziende private5

Health Technology

Finance

Ooxesis Biotech LLC

Finance

Commercial Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Chester Zygmont